TAVR as Anti-Inflammatory? An effect few imagined

We never saw it coming, such a pleiotropic effect: who would have though a mechanical device could have such a systemic anti-inflammatory effect? Transcatheter aortic valve replacement (TAVR) does in fact have it. 

TAVI como antiinflamatorio

The shear stress aortic stenosis produces activates multiple inflammatory responses mediated by monocytes. This study identified the most important mechanoreceptor, involved in the inflammatory cascade called Piezo-1. This receptor is a potentially druggable target, and although we have not yet been able to block it, we can prevent it from increasing inflammation by lowering shear stress with TAVR. 

The chance of aortic stenosis accelerating or provoking inflammation per se was unknown until now. 

TAVR has given us the unique opportunity to compare the activation status of monocytes under high shear stress (before TAVR) and under low shear stress (after TAVR).

The activation status of monocytes was determined using MAN-1 antibodies, which are specific for the activated B2 integrin Mac-1.


Read also: Computerized Tomography as First Coronary Study?


Activated monocytes adhere to stimulated endothelial cells, phagocytic activity, oxidized low density lipoproteins and cytokine expression. 

Different assays were carried out to collect this information before and after TAVR.

After TAVR, shear stress was reduced, with the resulting reduction of Mac-1 activity, cell adhesion, low density lipoprotein oxidation and inflammatory marker expression in the circulating monocytes. 


Read also: Considerations for Optimal Device Selection in TAVR.


Researchers also observed in the lab, under strictly controlled conditions, that shear stress-dependent calcium influx and monocyte adhesion are mediated by the mechanosensitive ion channel Piezo-1. 

Expression of this receptor depends on shear stress and it clearly drops after TAVR.

Conclusion

This study shows that shear stress produced by diseases such as severe aortic stenosis activates multiple monocyte functions mediated by the mechanosensitive Piezo-1. It also shows the anti-inflammatory effect of TAVR and therefore its new and unknow therapeutic benefit. 

CIRCULATIONA-A-120-045536

Original Title: Transcatheter Aortic Valve Implantation Represents an Anti-Inflammatory Therapy Via Reduction of Shear Stress–Induced, Piezo-1–Mediated Monocyte Activation.

Reference: Sara Baratchi et al. Circulation. 2020;142:1092–1105.  DOI: 10.1161/CIRCULATIONAHA.120.045536.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

TAVR in Small Annuli: What Valve Should We Use?

One of the major challenges of severe aortic stenosis are patients with small aortic annuli, defined as ≤430 mm² aortic valve area. This condition...

ACC 2025 | TAVI in Low-Risk Patients: 5-Year Outcomes of EVOLUTE LOW RISK

Transcatheter aortic valve implantation (TAVI) is a valid alternative to surgery in low-risk patients with severe aortic stenosis. However, one of its main limitations...

ACC 2025 | BHF PROTECT-TAVI: Are Cerebral Protection Systems Necessary in TAVI?

TAVI has seen a steady increase in use, though stroke continues to be one of its unwanted complications, mostly ischemic and, less frequently, hemorrhagic. The...

ACC-2025 Congress Second Day Key Studies

BHF PROTECT-TAVI (Kharbanda RK, Kennedy J, Dodd M, et al.)The largest randomized  trial carried out across 33 UK centers between 2020 and 2024, assessing...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

RACE Trial: Effect of Balloon Pulmonary Angioplasty and Riociguat on Right Ventricular Afterload and Function in Chronic Thromboembolic Pulmonary Hypertension

Even though pulmonary endarterectomy is the treatment of choice for chronic thromboembolic pulmonary hypertension (CTEPH), up to 40% of patients are not candidates because...

iFR- vs. FFR-Guided Coronary Revascularization: 5-Year Clinical Outcomes

The assessment of coronary stenosis using coronary physiology has become a key tool in guiding revascularization. The two most widely used techniques are fractional...

TAVR in Small Annuli: What Valve Should We Use?

One of the major challenges of severe aortic stenosis are patients with small aortic annuli, defined as ≤430 mm² aortic valve area. This condition...